gusperimus has been researched along with Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inagaki, J; Kimura, I; Majima, H; Masaoka, T; Niitani, H; Oguro, M; Ohno, R; Sanpi, K; Suzuoki, Y; Tamura, K | 1 |
| Inuma, H; Ishizuka, M; Kawada, M; Masuda, T; Someno, T; Takeuchi, T | 1 |
| Ishizuka, M; Kawada, M; Masuda, T; Takeuchi, T | 1 |
1 trial(s) available for gusperimus and Lymphoma
| Article | Year |
|---|---|
Phase I study of NKT-01.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Female; Guanidines; Hemoglobins; Humans; Leukemia; Leukocyte Count; Leukopenia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasms; Platelet Count; Regression Analysis | 1995 |
2 other study(ies) available for gusperimus and Lymphoma
| Article | Year |
|---|---|
The long-lasting antiproliferative effect of 15-deoxyspergualin through its spermidine moiety.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Guanidines; Inhibitory Concentration 50; Lymphoma; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
15-Deoxyspergualin inhibits Akt kinase activation and phosphatidylcholine synthesis.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Division; Enzyme Activation; Female; Guanidines; Humans; K562 Cells; Kinetics; Lymphoma; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Time Factors; Tumor Cells, Cultured | 2002 |